A standardized approach to test missense PNPLA1 rare genetic variants of uncertain significance in epidermal differentiation disorders
Status PubMed-not-MEDLINE Jazyk angličtina Země Nizozemsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
41624255
PubMed Central
PMC12860348
DOI
10.1016/j.xjidi.2025.100442
PII: S2667-0267(25)00098-0
Knihovny.cz E-zdroje
- Klíčová slova
- Functional genetics, Genodermatosis, Human epidermal equivalents, Ichthyosis, Skin barrier,
- Publikační typ
- časopisecké články MeSH
Congenital ichthyoses, now renamed epidermal differentiation disorders (EDDs) (syndromic EDD or nonsyndromic EDD), are rare, disabling conditions caused by sequence variations in epidermal barrier genes. However, 5-10% of variants, called "variants of uncertain significance" (VUS), remain uncharacterized, and their pathogenicity is not demonstrated. We developed an approach for classifying VUS in nonsyndromic EDD associated with variant in PNPLA1. We generated PNPLA1-knockout human keratinocytes. PNPLA1, encoded by a missense VUS or by the reference coding sequence, was expressed after lentiviral transduction in the PNPLA1-knockout cells. Transduced cells were used to produce human epidermal equivalents, and the functionality of the normal or VUS-encoded proteins was evaluated. Compared with PNPLA1-knockout human epidermal equivalents re-expressing normal PNPLA1, PNPLA1-knockout human epidermal equivalents showed disrupted synthesis of ω-O-acylceramide, the normal product of PNPLA1, as well as abnormal vesicle-like structures and immature cornified envelopes, characteristic of the epidermis of patients with PNPLA1 variants. Human epidermal equivalents expressing the PNPLA1 VUS showed similar abnormalities, consistent with an impaired PNPLA1 function. This work demonstrated a feasible strategy to help reclassifying missense VUS, which can be extended to other EDD-related genes. Although further efforts are needed to translate this approach into clinical practice and help overcome current diagnostic limitations, such models are valuable tools for pathophysiological and preclinical research on EDDs.
Centre de Microscopie Electronique Appliquée à la Biologie Toulouse University Toulouse France
Faculty of Pharmacy Charles University Hradec Králové Czech Republic
I2MC Inserm Toulouse University Toulouse France
Institute for Advanced Chemistry of Catalonia Barcelona Spain
MetaboHUB MetaToul National Infrastructure of Metabolomics and Fluxomics Toulouse France
RESTORE Institute UMR INSERM 1301 CNRS U5070 UT ENVT EFS Toulouse France
Zobrazit více v PubMed
Akiyama M. ABCA12 mutations and autosomal recessive congenital ichthyosis: a review of genotype/phenotype correlations and of pathogenetic concepts. Hum Mutat. 2010;31:1090–1096. PubMed
Akiyama M. Corneocyte lipid envelope (CLE), the key structure for skin barrier function and ichthyosis pathogenesis. J Dermatol Sci. 2017;88:3–9. PubMed
Akiyama M., Choate K., Hernández-Martín Á., Aldwin-Easton M., Bodemer C., Gostyński A., et al. Nonsyndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy. Br J Dermatol. 2025;193:619–641. PubMed
Akiyama M., Sugiyama-Nakagiri Y., Sakai K., McMillan J.R., Goto M., Arita K., et al. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J Clin Invest. 2005;115:1777–1784. PubMed PMC
Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–917. PubMed
Boyden L.M., Craiglow B.G., Hu R.H., Zhou J., Browning J., Eichenfield L., et al. Phenotypic spectrum of autosomal recessive congenital ichthyosis due to PNPLA1 mutation. Br J Dermatol. 2017;177:319–322. PubMed PMC
Cau L., Pendaries V., Lhuillier E., Thompson P.R., Serre G., Takahara H., et al. Lowering relative humidity level increases epidermal protein deimination and drives human filaggrin breakdown. J Dermatol Sci. 2017;86:106–113. PubMed PMC
Dickson M.A., Hahn W.C., Ino Y., Ronfard V., Wu J.Y., Weinberg R.A., et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol. 2000;20:1436–1447. PubMed PMC
Diociaiuti A., Pisaneschi E., Zambruno G., Angioni A., Novelli A., Boldrini R., et al. Novel PNPLA1 mutations in two Italian siblings with autosomal recessive congenital ichthyosis. J Eur Acad Dermatol Venereol. 2018;32:e110–e112. PubMed
Eckl K.M., De Juanes S., Kurtenbach J., Nätebus M., Lugassy J., Oji V., et al. Molecular analysis of 250 patients with autosomal recessive congenital ichthyosis: evidence for mutation hotspots in ALOXE3 and allelic heterogeneity in ALOX12B. J Invest Dermatol. 2009;129:1421–1428. PubMed
Eckl K.M., Krieg P., Küster W., Traupe H., André F., Wittstruck N., et al. Mutation spectrum and functional analysis of epidermis-type lipoxygenases in patients with autosomal recessive congenital ichthyosis. Hum Mutat. 2005;26:351–361. PubMed
Eckl K.M., Tidhar R., Thiele H., Oji V., Hausser I., Brodesser S., et al. Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length. J Invest Dermatol. 2013;133:2202–2211. PubMed
Evrard C., Faway E., De Vuyst E., Svensek O., De Glas V., Bergerat D., et al. Deletion of TNFAIP6 gene in human keratinocytes demonstrates a role for TSG-6 to retain hyaluronan inside epidermis. JID Innov. 2021;1 PubMed PMC
Farasat S., Wei M.H., Herman M., Liewehr D.J., Steinberg S.M., Bale S.J., et al. Novel transglutaminase-1 mutations and genotype-phenotype investigations of 104 patients with autosomal recessive congenital ichthyosis in the USA. J Med Genet. 2008;46:103–111. PubMed PMC
Feingold K.R., Elias P.M. Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim Biophys Acta. 2014;1841:280–294. PubMed
Fölster-Holst R., Naß C., Dähnhardt-Pfeiffer S., Freitag-Wolf S. Analysis of the structure and function of the epidermal barrier in patients with ichthyoses-clinical and electron microscopical investigations. J Eur Acad Dermatol Venereol. 2022;36:726–738. PubMed
Grall A., Guaguère E., Planchais S., Grond S., Bourrat E., Hausser I., et al. PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans. Nat Genet. 2012;44:140–147. PubMed
Grond S., Eichmann T.O., Dubrac S., Kolb D., Schmuth M., Fischer J., et al. PNPLA1 deficiency in mice and humans leads to a defect in the synthesis of omega-O-Acylceramides. J Invest Dermatol. 2017;137:394–402. PubMed PMC
Gutiérrez-Cerrajero C., Sprecher E., Paller A.S., Akiyama M., Mazereeuw-Hautier J., Hernández-Martín A., et al. Ichthyosis. Nat Rev Dis Primers. 2023;9:2. PubMed
Hernández-Martín Á., Paller A.S., Sprecher E., Akiyama M., Granier Tournier C., Aldwin-Easton M., et al. A proposal for a new pathogenesis-guided classification for inherited epidermal differentiation disorders. Br J Dermatol. 2025;193:544–548. PubMed
Lima Cunha D., Oram A., Gruber R., Plank R., Lingenhel A., Gupta M.K., et al. hiPSC-derived epidermal keratinocytes from ichthyosis patients show altered expression of cornification markers. Int J Mol Sci. 2021;22:1785–1800. PubMed PMC
Lulić A.M., Katalinić M. The PNPLA family of enzymes: characterisation and biological role. Arh Hig Rada Toksikol. 2023;74:75–89. PubMed PMC
Ohno Y., Kamiyama N., Nakamichi S., Kihara A. PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide. Nat Commun. 2017;8 PubMed PMC
Ohno Y., Nakamichi S., Ohkuni A., Kamiyama N., Naoe A., Tsujimura H., et al. Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation. Proc Natl Acad Sci USA. 2015;112:7707–7712. PubMed PMC
Oji V., Tadini G., Akiyama M., Blanchet Bardon C., Bodemer C., Bourrat E., et al. Revised nomenclature and classification of inherited ichthyoses: results of the First ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol. 2010;63:607–641. PubMed
Opálka L., Kováčik A., Sochorová M., Roh J., Kuneš J., Lenčo J., et al. Scalable synthesis of human ultralong chain ceramides. Org Lett. 2015;17:5456–5459. PubMed
Paller A.S., Teng J., Mazereeuw-Hautier J., Hernández-Martín Á., Granier Tournier C., Hovnanian A., et al. Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy. Br J Dermatol. 2025;193:592–618. PubMed
Pancarte M., Leignadier J., Courrech S., Serre G., Attia J., Jonca N. Strengthening the skin barrier by using a late cornified envelope 6A-derived biomimetic peptide. Exp Dermatol. 2024;33 PubMed
Pichery M., Huchenq A., Sandhoff R., Severino-Freire M., Zaafouri S., Opálka L., et al. PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega-O-acylceramide synthesis and skin permeability barrier. Hum Mol Genet. 2017;26:1787–1800. PubMed
Rabionet M., Gorgas K., Sandhoff R. Ceramide synthesis in the epidermis. Biochim Biophys Acta. 2014;1841:422–434. PubMed
Radner F.P., Marrakchi S., Kirchmeier P., Kim G.J., Ribierre F., Kamoun B., et al. Mutations in CERS3 cause autosomal recessive congenital ichthyosis in humans. PLoS Genet. 2013;9 PubMed PMC
Raghunath M., Hennies H.C., Velten F., Wiebe V., Steinert P.M., Reis A., et al. A novel in situ method for the detection of deficient transglutaminase activity in the skin. Arch Dermatol Res. 1998;290:621–627. PubMed
Reynier M., Allart S., Goudounèche D., Moga A., Serre G., Simon M., et al. The actin-based motor myosin Vb is crucial to maintain epidermal barrier integrity. J Invest Dermatol. 2019;139:1430–1438. PubMed
Richard G. Molecular genetics of the ichthyoses. Am J Med Genet C Semin Med Genet. 2004;131C:32–44. PubMed
Sprecher E., Ishida-Yamamoto A., Schwartz J., Akiyama M., Aldwin-Easton M., Choate K., et al. Palmoplantar epidermal differentiation disorders: a new classification toward pathogenesis-based therapy. Br J Dermatol. 2025;193:364–380. PubMed
Takeichi T., Hirabayashi T., Miyasaka Y., Kawamoto A., Okuno Y., Taguchi S., et al. SDR9C7 catalyzes critical dehydrogenation of acylceramides for skin barrier formation. J Clin Invest. 2020;130:890–903. PubMed PMC
Vahidnezhad H., Youssefian L., Saeidian A.H., Zeinali S., Mansouri P., Sotoudeh S., et al. Gene-targeted next generation sequencing identifies PNPLA1 mutations in patients with a phenotypic spectrum of autosomal recessive congenital ichthyosis: the impact of consanguinity. J Invest Dermatol. 2017;137:678–685. PubMed
Van Den Bogaard E., Ilic D., Dubrac S., Tomic-Canic M., Bouwstra J., Celli A., et al. Perspective and consensus opinion: good practices for using organotypic skin and epidermal equivalents in experimental dermatology research. J Invest Dermatol. 2021;141:203–205. PubMed PMC
van Smeden J., Janssens M., Gooris G.S., Bouwstra J.A. The important role of stratum corneum lipids for the cutaneous barrier function. Biochim Biophys Acta. 2014;1841:295–313. PubMed
Wertheim-Tysarowska K., Osipowicz K., Woźniak K., Sawicka J., Mika A., Kutkowska-Kaźmierczak A., et al. Molecular analysis of inherited disorders of cornification in polish patients show novel variants and functional data and provokes questions on the significance of secondary findings. Orphanet J Rare Dis. 2024;19:413. PubMed PMC
Youssefian L., Vahidnezhad H., Saeidian A.H., Touati A., Sotoudeh S., Mahmoudi H., et al. Autosomal recessive congenital ichthyosis: genomic landscape and phenotypic spectrum in a cohort of 125 consanguineous families. Hum Mutat. 2019;40:288–298. PubMed
Zhang J., Yao Y., He H., Shen J. Clinical interpretation of sequence variants. Curr Protoc Hum Genet. 2020;106:e98. PubMed PMC
Zimmer A.D., Kim G.J., Hotz A., Bourrat E., Hausser I., Has C., et al. Sixteen novel mutations in PNPLA1 in patients with autosomal recessive congenital ichthyosis reveal the importance of an extended patatin domain in PNPLA1 that is essential for proper human skin barrier function. Br J Dermatol. 2017;177:445–455. PubMed